Pharmacotherapy of aggressive behavior

Annals of Pharmacotherapy

Volumn 30, Issue 3, 1996, Pages 278-287

  Pabis, Dennis J ^a   Stanislav, Steven W ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Healthcare Rehabilitation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CLOZAPINE; DOPAMINE; ELTOPRAZINE; FLUOXETINE; LITHIUM; NEUROLEPTIC AGENT; NORADRENALIN; PINDOLOL; PROPRANOLOL; SERENIC AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID;

AGGRESSION; AGITATION; BEHAVIOR THERAPY; CLINICAL PRACTICE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; GABAERGIC SYSTEM; HUMAN; LIMBIC CORTEX; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029986631     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000312     Document Type: Review

References (106)

1. Stedman's medical dictionary. 24th ed. Baltimore: Williams and Wilkins, 1982:33.
2. Nilsson K, Palmstierna T, Wistedt B. Aggressive behavior in hospitalized psychogeriatric patients. Acta Psychiatr Scand 1988;78:172-5.
3. Maletzky BM. The episodic dyscontrol syndrome. Dis Nerv Sys 1973;34:178-85
4. Winger J, Schirm V, Stewart D. Aggressive behavior in long-term care. J Psychosoc Nurs Ment Health Serv 1987;25:28-33.
5. Haller RM, Deluty RH. Assaults on staff by psychiatric in-patients: a critical review. Br J Psychiatry 1988;152:174-9.
6. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed Washington, DC: American Psychiatric Association, 1994.
7. Burrowes KL, Hales RE, Arrington E. Research on the biological aspects of violence. Psychiatr Clin North Am 1988,11:499-509.
8. Eichelman BS. Neurochemical and psychopharmacologic aspects of aggressive behavior. Annu Rev Med 1990;41:149-58.
9. Valzelli L Psychobiology of aggression and violence. New York: Raven Press, 1981.
10. Devinsky O, Bear D. Varieties of aggressive behavior in temporal lobe epilepsy. Am J Psychiatry 1984;141:651-6.
11. Stevens JR, Hermann BP. Temporal lobe epilepsy, psychopathology. and violence: the state of the evidence. Neurology 1981;31:1127-32.
12. Post R, Uhde T, Putnam F, Ballenger JC, Berrettini WH. Kindling and carbamazepine in affective illness. J Nerv Ment Dis 1982;170:717-31.
13. Maletzky BM. The episodic dyscontrol syndrome. Dis Nerv Sys 1973;34:178-85.
14. Bacy-Y-Rita G, Lion JR, Climent CE, Ervin FR. Episodic dyscontrol: a study of 130 violent patients. Am J Psychiatry 1971;127:1463-8.
15. White SM, Kucharik RF, Moyer JA. Effects of serotonergic agents on isolation-induced aggression. Pharmacol Biochem Behav 1991;39:729-36.
16. Molina V, Ciesielski L, Gobaille S, Isel F, Mandel P. Inhibition of mouse killing behavior by serotonin-mimetic drugs: effects of partial alterations of serotonin neurotransmission. Pharmacol Biochem Behav 1987;27:123-31.
17. Morand C, Young SN, Ervin FR. Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry 1983;18:575-8.
18. Young SN, Pihl RO, Ervin FR. The effect of altered tryptophan levels on mood and behavior in normal human males. Clin Neuropharmacol 1986;9(suppl 4).516-8.
19. Volavka J, Crowner M, Brizer D, Convit A, van Praag H, Suckow RF. Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry 1990;28:728-32.
20. Sheard MH. Clinical pharmacology of aggressive behavior. Clin Neuropharmacol 1988;6:483-92.
21. Brown GL, Goodwin FK, Ballenger JC, Goyer PF. Cerebrospinal fluid amine metabolites and cyclic nucleotides in human aggression. Psychopharmacol Bull 1981;17:63-5.
22. van Praag HM. Serotonergic dysfunction and aggression control (editorial). Psychol Med 1991,21:15-9.
23. Coccaro EF. Central serotonin and impulsive aggression. Br J Psychiatry 1989;155(suppl 8):52-62.
24. Fishbein DH, Lozovsky D, Jaffe JH. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 1989;25:1049-66.
25. Golden RN, Gilmore JH, Corrigan MH, Ekstrom RD, Knight BT, Garbutt JC. Serotonin, suicide, and aggression: clinical studies. J Clin Psychiatry 1991;52(suppl 12):61-9.
26. Linnoila M, Virkkunen M. Biologic correlates of suicide risk and aggressive behavioral traits. J Clin Psychopharmacol 1992;12(suppl 2):19S-20S.
27. Brown GL, Linnoila MI. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence J Clin Psychiatry 1990;51(suppl 4):31-41.
28. Yudofsky SC, Silver JM, Schneider SE. Pharmacologic treatment of aggression. Psych Ann 1987;17:397-407.
29. Richardson JS, Zaleski WA. Naloxone and self-mutilation. Biol Psychiatry 1983;18:99-101.
30. Sandman CA, Datta PC, Barron J, Hoehler FK, Williams C, Swanson JM. Naloxone attenuates self-abusive behavior in developmentally disabled clients. Appl Res Ment Retard 1983;4:5-11.
31. Berky PS. Combativeness: a treatable problem in the elderly patient. Today's OR Nurse 1987;9:20-3.
32. Ratey JJ, Leveroni C, Kilmer D, Gutheil C, Swartz B. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 1993;54:219-23.
33. Moos RH. Evaluating treatment environments: a social ecological approach. New York: Wiley, 1974.
34. Yudofsky SC, Silver JM, Hales RE. Treatment of aggressive disorders. In: Schatzberg AF, Nemeroff CB, eds. The American psychiatric press textbook of psychopharmacology. 1st ed. Washington, DC: American Psychiatric Press, 1995:735-51.
35. Salzman C. Use of benzodiazepines to control disruptive behavior in inpatients. J Clin Psychiatry 1988;49(suppl 12):13-5.
36. Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, et al. Parenteral lorazepam versus patenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 1991;52:177-80.
37. Dietch JT, Jennings RK. Aggressive dyscontrol in patients treated with benzodiazepines J Clin Psychiatry 1988;49:184-8.
38. Gardos G. Disinhibition of behavior by antianxiety drugs. Psychosomatics 1980;21:1025-6.
39. Dubin WR. Rapid tranquilization: antipsychotic or benzodiazepine? J Clin Psychiatry 1988;49(suppl 12):5-11.
40. Marder SR, Ames D, Wirshing WC, Van Putten T. Schizophrenia. Psychiatr Clin North Am 1993;16:567.
41. Sheard MH. Lithium in the treatment of aggression. J Nerv Ment Dis 1975;160.108-18.
42. Sheard MH. Effect of lithium on human aggression. Nature 1971;230:113-4.
43. Sheard MH, Marini JL, Bridges CI, Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-13.
44. Tupin JP, Smith DB, Clanon TL, Kim LI, Nugent A, Groupe A. The long-term use of lithium in aggressive prisoners. Comp Psychiatry 1973;14:311-7.
45. Worrall EP, Moody JP, Naylor GJ. Lithium in nonmanic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry 1975;126:464-8.
46. Craft M, Ismail IA, Krishnamurti D, Mathews J, Regan A, Seth RV, et al. Lithium in the treatment of aggression in mentally handicapped patients: a double-blind trial. Br J Psychiatry 1987;150:685-9.
47. Spreat S, Behar D, Reneski B, Miazzo P. Lithium carbonate for aggression in mentally retarded persons. Comp Psychiatry 1989;30:505-11.
48. Langee HR. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders. Am J Ment Retard 1990;94:448-52.
49. Glenn MB, Wroblewski B, Parziale J, Levine L, Whyte J, Rosenthal M. Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am J Phys Med Rehabil 1989;68:221-6.
50. Ritrovato CA, Weber SS, Dufresne RL. Nadolol in the treatment of aggressive behavior associated with schizophrenia. Clin Pharm 1989;8:132-5.
51. Ratey JJ, Morrill R, Oxenkrug G. Use of propranolol for provoked and unprovoked episodes of rage Am J Psychiatry 1983;140:1356-7.
52. Yudofsky S, Williams D, Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. Am J Psychiatry 1981;138:218-20.
53. Greendyke RM, Kanter DR, Schuster DB, Verstreate S, Wootton J. Propranolol treatment of assaultive patients with organic brain disease. J Nerv Ment Dis 1986;174:290-4.
54. Sheppard GP. High-dose propranolol in schizophrenia. Br J Psychiatry 1979,134:470-6.
55. Tyrer PF, Lader MH. Response to propranolol and diazepam in the treatment of somatic anxiety and psychic anxiety. Br Med J 1974;11:15-6.
56. Sorgi PJ, Ratey JJ, Polakoff S. Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia. Am J Psychiatry 1986;143:775-6.
57. Luchins DJ, Dojka D Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded. Psychopharmacol Bull 1989;25.372-5.
58. Ratey JJ, Sorgi P, O'Driscoll GA, Sands S, Daehler ML, Fletcher JR, et al. Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry 1992;53.41-6.
59. Polakoff SA, Sorgi PJ, Ratey JJ. Treatment of impulsive and aggressive behavior with nadolol (letter). J Clin Psychopharmacol 1986;6:125-6.
60. Greendyke RM, Kanter DR. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 1986,47:423-6
61. Mattes JA. Metoprolol for intermittent explosive disorder. Am J Psychiatry 1985;142:1108-9.
62. Mattes JA, Rosenberg J, Mays D. Carbamazepine versus propranolol in patients with uncontrolled rage outbursts: a random assignment study. Psychopharmacol Bull 1984;20:98-100.
63. Neppe VM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEC temporal lobe abnormalities. J Clin Psychiatry 1983;44:326-31.
64. Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 1986;143:519-22.
65. Reid A, Naylor G, Kay D. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive severely mentally handicapped patients. Psychol Med 1981;11:109-13.
66. Hakoloa HP, Laulumaa VA. Carbamazepine in treatment of violent schizophrenics (letter). Lancet 1982;1:1358.
67. Mattes JA. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatr Clin Neurosci 1990;2:159-64.
68. Yassa R, Dupont D. Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report. Can J Psychiatry 1983;28:566-8.
69. Young JL, Hillbrand M. Carbamazepine lowers aggression: a review. Bull Am Acad Psychiatry Law 1994;22:53-61.
70. Hart R, Easton JD. Carbamazepine and hematologic monitoring. Ann Neurol 1982;11:309-12.
71. Sovner R. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. J Clin Psychiatry 1989;50(suppl 3):40-3.
72. Kastner T. Valproic acid for the treatment of children with mental retardation and mood symptomatology. Pediatrics 1990;86:467-72.
73. Mattes JA. Valproic acid for nonaffective aggression in the mentally retarded. J Nerv Ment Dis 1992;180:601-2.
74. Mazure CM, Druss BG, Cellar JS. Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol. J Am Geriatr Soc 1992;40:914-6.
75. Ratey J, Sovner R, Parks A, Rogentine K. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J Clin Psychiatry 1991;52:159-62.
76. Stanislav SW, Fabre T, Crismon ML, Childs A. Buspirone's efficacy in organic-induced aggression. J Clin Psychopharmacol 1994;14:126-30.
77. Colella RF, Ratey JJ, Glaser AI. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone. Int J Psychiatry Med 1992;22:351-6.
78. Quiason N, Ward D, Kitchen T. Buspirone for aggression (letter). J Am Acad Child Adolesc Psychiatry 1991;30:1026.
79. Gedye A. Buspirone alone or with serotonergic diet reduced aggression in a developmentally disabled adult. Biol Psychiatry 1991;30:88-91.
80. O'Neil M, Page N, Adkins WN, Eichelman B. Tryptophan-trazodone treatment of aggressive behaviour. Lancet 1986,2:859-60.
81. Simpson DM, Foster D. Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry 1986;47:191-3.
82. Wilcox GK, Stevens J, Parkins A. Trazodone/tryptophan for aggressive behaviour (letter). Lancet 1987;1:929-30.
83. Gedye A. Trazodone reduced aggressive and self-injurious movements in a mentally handicapped male patient with autism. J Clin Psychopharmacol 1991;11-275-6.
84. Pinner E, Rich CL. Effects of trazodone on aggressive behavior in seven patients with organic mental disorders. Am J Psychiatry 1988;145:1295-6.
85. Zubieta JK, Alessi NE. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children. J Clin Psychopharmacol 1992;12:346-51.
86. Patterson BD, Srisopark MM. Severe anorexia and possible psychosis or hypomania after trazodone-tryptophan treatment of aggression (letter). Lancet 1989;1:1017.
87. Coccaro EF, Astill JL, Herbert JL, Schut AG. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients (letter). J Clin Psychopharmacol 1990;10:373-5.
88. Markowitz PI. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study. J Clin Psychopharmacol 1992;12:27-31.
89. Sobin P, Schneider L, McDermott H. Fluoxetine in the treatment of agitated dementia (letter). Am J Psychiatry 1989;146:1636.
90. Kavoussi RJ, Liu J, Coccaro E. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-41.
91. Campbell JJ, Duffy JD. Sertraline treatment of aggression in a developmentally disabled patient. J Clin Psychiatry 1995;56:123-4.
92. Michals ML, Crismon ML, Roberts S, Childs A. Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol 1993;13-198-203
93. Volavka J, Zito JM, Vitrai J, Czobor P. Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol 1993;13:287-9.
94. Olivier B, Mos J, Raghoebar M, de Koning P, Mak M. Serenics. Prog Drug Res 1994,42:167-308.
95. Tiihonen J, Hakola P, Paanila J, Turtiainen M. Eltoprazinc for aggression in schizophrenia and mental retardation (letter). Lancet 1993;341:307.
96. 1 receptor sites in the rat brain: an autoradiographic study. Eur J Pharmacol 1990;177:55-66.
97. Miller SW. Drug product selection: implications for the geriatric patient (letter). Consult Pharm 1990;5:30.
98. Rovner BW, David A, Lucas-Blaustein MJ, Conklin B, Filipp L, Tune L. Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry 1988;145:107-9.
99. Ray WA. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303-7.
100. Petrie WM, Ban TA. Propranolol in organic agitation (letter). Lancet 1981;1:324.
101. Risse SC, Lampe TH, Cubberley L. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease. J Clin Psychiatry 1987,48:207-8.
102. Simpson DM, Foster D. Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry 1986;47:191-3.
103. Greenwald BS, Marin DB, Silverman SM. Serotonergic treatment of screaming and banging in dementia. Lancet 1986;2:1464-5.
104. Mentes JC, Ferrario J. Calming aggressive reactions: a preventive program J Gerontol Nurs 1989;15:22-7.
105. Jones MK. Patient violence: report of 200 incidents. J Psychosoc Nurs Ment Health Serv 1985;23:12-7.
106. Gleason RP, Schneider LS. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry 1990;51.115-8.